Saito, G., Oya, Y., Taniguchi, Y., Kawachi, H., Daichi, F., Matsumoto, H., Iwasawa, S., Suzuki, H., Niitsu, T., Miyauchi, E., Yokoi, T., Yokoyama, T., Uenami, T., Sakata, Y., Arai, D., Okada, A., Nagata, K., Teraoka, S., & Kokubo, M. (2021). real-world survey of pneumonitis and its impact on durvalumab consolidation therapy in patients with non-small cell lung cancer who received chemoradiotherapy after durvalumab approval (HOPE-005/CRIMSON). Lung cancer, 161, 86–93. http://access.bl.uk/ark:/81055/vdc_100144490662.0x000046